These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 568225)

  • 1. [Studies of the monoamine blood-brain barrier mechanism by means of the Falck-Hillarp and glyoxalate methods. Comparative studies].
    Lessel W; Dietzmann K
    Neuropatol Pol; 1978; 16(3):375-84. PubMed ID: 568225
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The localization of monoaminergic blood-brain barrier mechanisms.
    Bertler A; Falck B; Owman C; Rosengrenn E
    Pharmacol Rev; 1966 Mar; 18(1):369-85. PubMed ID: 5904153
    [No Abstract]   [Full Text] [Related]  

  • 4. Biogenic amines in the developing brain.
    Eiduson S
    UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
    [No Abstract]   [Full Text] [Related]  

  • 5. Applications of the fluorescence technique of Falck-Hillarp in studies on connections in the central nervous system.
    Kubasik A
    Folia Morphol (Warsz); 1974; 33(3):269-77. PubMed ID: 4139091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Brain monoamine oxidase and its inhibitors in gerontology (review of the literature)].
    Burchinbskiĭ SG; Kuznetsova SM
    Vopr Med Khim; 1988; 34(4):2-9. PubMed ID: 3057739
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
    Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
    Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M; Semmel M; Schor JM
    Enzymologia; 1968 Jul; 34(5):299-303. PubMed ID: 5672567
    [No Abstract]   [Full Text] [Related]  

  • 9. Type B monoamine oxidase activity in human brain malignant tumors.
    Marcozzi G; Befani O; Mondovì B
    Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity.
    Bhattacharya SK; Chakrabarti A; Sandler M; Glover V
    Indian J Exp Biol; 1996 Dec; 34(12):1190-3. PubMed ID: 9246908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties of monoamine oxidase in the brain of mongolian gerbils during cerebral ischemia].
    Goroshinskaia IA; Stoianovich T; Michich DV; Mrshulia BB
    Vopr Med Khim; 1989; 35(5):112-5. PubMed ID: 2617926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroprotective effect of monoamine oxidase monoclonal antibody against vasogenic brain edema in rats].
    Li Q; Lu BX; Wang XY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):53-6. PubMed ID: 14724097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(3):633-44. PubMed ID: 5942129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of an aminotetralin derivative with pressor action on the monoamine oxidase activity of the brain and liver of rats].
    Bogoslovova T; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1987; 26(4):37-9. PubMed ID: 3446487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 17. Immobilization stress increases endogenous monoamine oxidase (MAO) inhibitor in rat liver.
    Obata T
    Bioelectrochemistry; 2007 May; 70(2):308-10. PubMed ID: 16797252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 19. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    Holt A; Berry MD; Boulton AA
    Neurotoxicology; 2004 Jan; 25(1-2):251-66. PubMed ID: 14697900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface.
    Hardebo JE; Owman C
    Ann Neurol; 1980 Jul; 8(1):1-31. PubMed ID: 6105837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.